All News

While inflammation may not be associated with certain cancer-related symptoms, it can impact depression and physical activity levels in anyone, recent research showed.

Reblozyl treatment in patients with anemia from lower-risk myelodysplastic syndromes achieved a greater independence from red blood cell transfusions compared with treatment with epoetin alfa.

I will continue to say that I am a “survivor,” and that is the best title I could ever receive.

If the FDA approves zolbetuximab, this would mark the first CLDN18.2-targeting monoclonal antibody to treat patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma.

Patients with non-microsatellite instability-high metastatic colorectal cancer had better survival rates from the botensilimab and balstilimab combination.

Fit patients with chronic lymphocytic leukemia treated with Venclexta and Gazyva, regardless of the use of Imbruvica, experienced improvements in progression-free survival and were more likely to obtain undetectable minimal residual disease.

When paired with the chemotherapy combination doxorubicin, vinblastine and dacarbazine, Keytruda resulted in 100% overall survival in the findings from a new study of adult patients with classic Hodgkin lymphoma.

Simultaneous administration of the novel oral S-1 chemotherapy and SIB-RT could improve survival rates for patients aged 70 and older with esophageal squamous cell carcinoma (ESCC).

A blood test protocol proved to be more effective than US Preventative Services Task Force criteria for predicting which patients are at a higher risk of dying from lung cancer.

From YouTuber Grace Helbig announcing her cancer diagnosis to the NFL’s Foster Moreau being in full remission, here’s what’s happening in the oncology space this week.

Being treated for Hodgkin lymphoma during childhood can result in fertility declines, a recent study shows.

Patients with advanced cancers who live in states that expanded Medicaid were more likely to receive early palliative care, although utilization remains low in the U.S.

Patients with both metastatic non-small cell lung cancer and preexisting diabetes mellitus have different outcomes depending on treatment and treatment combinations, particularly with Keytruda and chemotherapy

I was diagnosed with cancer just as the pandemic hit.

Patients being treated for a myeloproliferative neoplasm should be open with their care team about any side effects they experience, an expert said.

Artificial intelligence was used to develop a predictive biomarker to identify patients with intermediate-risk prostate cancer who would benefit from adding androgen deprivation therapy to radiotherapy.

Zeno showed promise in treating patients with advanced, unresectable or metastatic NRG1-fusion pancreatic cancer.

Patients 65 years and older with NSCLC and undergoing treatment with immunotherapy, chemotherapy and/or targeted therapy were more likely to have worse survival outcomes and declines in activity of daily living.

Raising awareness for cancer survivors is important, and I try to do just that.

Caregiver burden was prevalent among caregivers of patients with head and neck cancer, due to lack of patient employment and poor health-related quality of life.

Findings from a study conducted in women with a history of breast cancer demonstrated that treatment with donepezil, which is typically used to treat symptoms of Alzheimer’s disease and dementia, did not improve cognitive impairment, or “chemo brain.”

Cryotherapy may reduce the occurrence of peripheral neuropathy in patients with breast cancer undergoing chemotherapy with paclitaxel and nab-paclitaxel, according to recent findings from an analysis.

Dr. Susan Love, founder of the Dr. Susan Love Foundation for Breast Cancer Research, died of leukemia.

Patients with lower risk myelodysplastic syndrome may now receive imetelstat — despite it not being FDA-approved.

The final overall survival results of the PAOLA-1/ENGOT-ov25 trial confirmed the drug combination as “one of the standards of care” for some populations of patients with ovarian cancer.

Kim Stuck credits her cannabis use to the fact that she maintained her weight, was able to work out and was not in pain during breast cancer treatment.

In my wife’s family, the same pathogenic BRCA2 mutation is shared among 1st, 2nd, 3rd, 4th, 5th and possibly 6th degree (too young to test) blood relatives.

When it came to content on the mental health effects of prostate cancer, a review of YouTube videos found the results to be lacking.